Turning stats into outcomes
June 05, 2013
The US Food and Drug Administration is planning to tighten its scrutiny of companion diagnostics, the agency's Commissioner Margaret Hamburg has told the assembled throng at ASCO
June 28, 2012
The pharmaceutical industry's recent emphasis on quality over quantity is working, as evidenced by a lower number of early-phase projects and fewer Phase III projects being terminated, combined with an increase in regulatory approvals, says a new report.
July 21, 2011
A lack of evidence linking diagnostic tests to health outcomes is hindering the growth of personalised medicines in the US, according to a new study.
May 31, 2011
The UK's Technology Strategy Board and Medical Research Council (MRC) are to jointly invest over £3.7 million in seven major project which, they say, will help place the UK at the forefront of developments into personalised medicine.
PharmaTimes 2013 Copyright | RSS Feed Subscriptions